Subunit vaccine containing particle carriers and application of subunit vaccine

A subunit vaccine and carrier technology, applied to medical preparations containing active ingredients, antibody medical ingredients, viruses/bacteriophages, etc., can solve problems such as complex production process, high R&D cost, and long R&D cycle, and avoid aggregation and precipitation , reduce R&D costs, and simplify the production process

Active Publication Date: 2021-04-13
百葵锐(深圳)生物科技有限公司
View PDF3 Cites 2 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

Subunit bacterial vaccines also have disadvantages similar to those of VLP vaccines, such as serious side effects caused by protein misaggregation, long R&D cycle, high R&D costs, and complex production processes, etc.

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Subunit vaccine containing particle carriers and application of subunit vaccine
  • Subunit vaccine containing particle carriers and application of subunit vaccine
  • Subunit vaccine containing particle carriers and application of subunit vaccine

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0042] The preparation of embodiment 1 nano virus-like particle novel coronavirus COVID-19 vaccine

[0043] This example is a preparation of a novel coronavirus COVID-19 vaccine based on protein self-assembly controllable nano-virus-like particles. Among them, the antigenic protein is selected from the novel coronavirus SARS-CoV-2 RBD-SD1 protein, and the antigenic protein is connected with a polypeptide linker and a silica binding peptide. Among them, the role of the linker is to connect the binding peptide and the antigenic protein, and the role of the silica-binding peptide is to increase the specific binding force between the antigenic protein and the silica nanoparticles. The expression system is mammalian cells. The antigenic protein connected to the linker and the binding peptide is assembled into a virus-like COVID-19 vaccine by combining with silica nanoparticles with a particle size of 20nm. The principle is as follows figure 2 shown

[0044] Polyclonal antibodie...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention discloses a subunit vaccine containing particle carriers and application of the subunit vaccine, and provides a novel coronavirus COVID-19 vaccine containing nano virus-like particles by taking the novel coronavirus COVID-19 vaccine as an example. According to the scheme, different nano / micron materials are used as carriers, self-assembly of subunit antigens on the carriers is achieved, and the surface structure of viruses or bacteria is fully simulated. The advantages of improving the immunogenicity, simplifying the production process and reducing the production cost are realized. Different antigen proteins are chemically covalently coupled or specifically bound and adsorbed to nano / microsphere particles with different particle sizes through physical adsorption (electrostatic interaction, hydrophobic interaction, hydrogen bonds and other specific physical effects) to form viroid particles with structures similar to those of viruses or bacteroid particles with structures similar to those of bacteria, so that the immunogenicity of the vaccine is improved.

Description

technical field [0001] The invention belongs to the field of biotechnology, and relates to a subunit vaccine containing particle carriers and applications thereof. Background technique [0002] Vaccines remain the most cost-effective and successful interventions for the control and prevention of infectious diseases, identified as a key factor in the 30-year increase in average human lifespan achieved in the 20th century. Widespread use of vaccines has led to the eradication of naturally occurring smallpox infection, the near eradication of polio, and dramatic reductions in the incidence of diseases such as measles, rubella, mumps, pertussis, and diphtheria, all of which have contributed to lowering the global mortality rate from infectious diseases and morbidity. [0003] Traditional vaccine strategies are mainly based on attenuating or inactivating pathogens (such as viruses and live bacteria). These strategies have shown promising results in inducing potent B- and T-cell...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
IPC IPC(8): A61K39/00A61K39/215A61P31/14A61P11/00
CPCA61K39/00A61K39/12A61P31/14A61P11/00A61K2039/5258C12N2770/20034Y02A50/30
Inventor赵兴旺李华珍章家泉
Owner百葵锐(深圳)生物科技有限公司